These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 26169281)
1. Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) - the ESMERALDA trial. Habermehl D; Naumann P; Bendl R; Oelfke U; Nill S; Debus J; Combs SE Radiat Oncol; 2015 Jul; 10():143. PubMed ID: 26169281 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy. Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129 [TBL] [Abstract][Full Text] [Related]
3. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers. Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT? Berchtold J; Winkler C; Karner J; Groher M; Gaisberger C; Sedlmayer F; Wolf F Strahlenther Onkol; 2024 Mar; 200(3):195-201. PubMed ID: 37626226 [TBL] [Abstract][Full Text] [Related]
5. Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT. Wust P; Joswig M; Graf R; Böhmer D; Beck M; Barelkowski T; Budach V; Ghadjar P Strahlenther Onkol; 2017 Sep; 193(9):700-706. PubMed ID: 28466155 [TBL] [Abstract][Full Text] [Related]
6. To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy. Babic S; Lee Y; Ruschin M; Lochray F; Lightstone A; Atenafu E; Phan N; Mainprize T; Tsao M; Soliman H; Sahgal A J Appl Clin Med Phys; 2018 Mar; 19(2):111-120. PubMed ID: 29363282 [TBL] [Abstract][Full Text] [Related]
7. The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors. Qiu JJ; Ge W; Zhang L; Yao Y; Zheng X Technol Cancer Res Treat; 2016 Oct; 15(5):674-82. PubMed ID: 26206766 [TBL] [Abstract][Full Text] [Related]
8. Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers. Nishioka K; Shimizu S; Shinohara N; Ito YM; Abe T; Maruyama S; Katoh N; Kinoshita R; Hashimoto T; Miyamoto N; Onimaru R; Shirato H Radiat Oncol; 2017 Mar; 12(1):44. PubMed ID: 28249609 [TBL] [Abstract][Full Text] [Related]
9. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis. Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006 [TBL] [Abstract][Full Text] [Related]
10. Adequacy of inhale/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT. Yang W; Fraass BA; Reznik R; Nissen N; Lo S; Jamil LH; Gupta K; Sandler H; Tuli R Radiat Oncol; 2014 Jan; 9():11. PubMed ID: 24401365 [TBL] [Abstract][Full Text] [Related]
11. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815 [TBL] [Abstract][Full Text] [Related]
12. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring. Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111 [TBL] [Abstract][Full Text] [Related]
13. Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography. Guckenberger M; Sweeney RA; Wilbert J; Krieger T; Richter A; Baier K; Mueller G; Sauer O; Flentje M Int J Radiat Oncol Biol Phys; 2008 May; 71(1):297-304. PubMed ID: 18406894 [TBL] [Abstract][Full Text] [Related]
14. Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer. Mangesius J; Seppi T; Ibrahim R; Fleischmann K; Ginestet A; Vorbach S; Hart T; Pointner M; Mangesius S; Ganswindt U Phys Eng Sci Med; 2023 Dec; 46(4):1365-1374. PubMed ID: 37523057 [TBL] [Abstract][Full Text] [Related]
15. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Heijkoop ST; Langerak TR; Quint S; Bondar L; Mens JW; Heijmen BJ; Hoogeman MS Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):673-9. PubMed ID: 25151538 [TBL] [Abstract][Full Text] [Related]
16. Effect of a Device-Free Compressed Shell Fixation Method on Hepatic Respiratory Movement: Analysis for Respiratory Amplitude of the Liver and Internal Motions of a Fiducial Marker. Hashimoto S; Katsurada M; Muramatsu R; Asai K; Tanaka K; Hayashi K; Kibe Y; Nakajima K; Hattori Y; Iwata H; Mizoe JE; Ogino H; Shibamoto Y Pract Radiat Oncol; 2019 Mar; 9(2):e149-e155. PubMed ID: 30336269 [TBL] [Abstract][Full Text] [Related]
17. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity. Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764 [TBL] [Abstract][Full Text] [Related]
18. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients. Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345 [TBL] [Abstract][Full Text] [Related]
19. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy. Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489 [TBL] [Abstract][Full Text] [Related]
20. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers. Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]